blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1135121

EP1135121 - COMBINATION OF DULOXETINE WITH NON-STEROIDAL ANTIINFLAMMATORY DRUG FOR TREATING PAIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.01.2004
Database last updated on 22.08.2024
Most recent event   Tooltip03.12.2004Lapse of the patent in a contracting state
New state(s): IE		published on 19.01.2005  [2005/03]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [2001/39]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / IYENGAR, Smriti
1507 Redwood Drive
Carmel, IN 46032 / US
02 / JONES, Carrie, Kimberly
221 East Michigan Apartment 605
Indianapolis, IN 46204 / US
03 / SHANNON, Harlan, Edgar
4229 Rolling Springs Drive
Carmel, IN 46033 / US
 [2001/39]
Representative(s)Vaughan, Jennifer Ann
Lilly Research Centre
Erl Wood Manor
Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [2001/39]Vaughan, Jennifer Ann
Lilly Research Centre, Erl Wood Manor
Windlesham, Surrey GU20 6PH / GB
Application number, filing date99960277.410.11.1999
[2001/39]
WO1999US26655
Priority number, dateUS19980108370P13.11.1998         Original published format: US 108370 P
[2001/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0028980
Date:25.05.2000
Language:EN
[2000/21]
Type: A2 Application without search report 
No.:EP1135121
Date:26.09.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 25.05.2000 takes the place of the publication of the European patent application.
[2001/39]
Type: B1 Patent specification 
No.:EP1135121
Date:12.03.2003
Language:EN
[2003/11]
Search report(s)International search report - published on:EP27.07.2000
ClassificationIPC:A61K31/38, A61K31/19, A61P29/00
[2001/39]
CPC:
A61K31/415 (EP,US); A61K31/38 (EP,US); A61K31/40 (EP,US);
A61K31/405 (EP,US); A61K31/60 (EP,US); A61K45/06 (EP,US);
A61P25/04 (EP); A61P29/00 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/38, A61K2300/00 (US,EP);
A61K31/38, A61K31/165 (US,EP);
A61K31/38, A61K31/19 (US,EP);
A61K31/38, A61K31/195 (EP,US);
A61K31/38, A61K31/365 (US,EP);
A61K31/405, A61K2300/00 (US,EP);
A61K31/405, A61K31/38 (EP,US);
A61K31/40, A61K2300/00 (US,EP);
A61K31/40, A61K31/38 (EP,US);
A61K31/415, A61K2300/00 (US,EP);
A61K31/415, A61K31/38 (US,EP);
A61K31/60, A61K2300/00 (US,EP);
A61K31/60, A61K31/38 (US,EP)
(-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/39]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:KOMBINATION VON DULOXETIN MIT NICHTSTEROID-ENTZÜNDUNGSHEMMERN FÜR DIE BEHANDLUNG VON SCHMERZ[2001/39]
English:COMBINATION OF DULOXETINE WITH NON-STEROIDAL ANTIINFLAMMATORY DRUG FOR TREATING PAIN[2001/39]
French:METHODE DE TRAITEMENT DE LA DOULEUR[2001/39]
Entry into regional phase13.06.2001National basic fee paid 
13.06.2001Designation fee(s) paid 
13.06.2001Examination fee paid 
Examination procedure15.05.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
08.05.2001Amendment by applicant (claims and/or description)
13.06.2001Examination requested  [2001/39]
08.08.2002Communication of intention to grant the patent
18.12.2002Fee for grant paid
18.12.2002Fee for publishing/printing paid
Opposition(s)15.12.2003No opposition filed within time limit [2004/10]
Fees paidRenewal fee
07.11.2001Renewal fee patent year 03
02.12.2002Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.03.2003
BE12.03.2003
CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
DK12.06.2003
SE12.06.2003
PT16.06.2003
CY10.11.2003
IE10.11.2003
LU10.11.2003
MC30.11.2003
[2005/03]
Former [2005/02]AT12.03.2003
BE12.03.2003
CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
DK12.06.2003
SE12.06.2003
PT16.06.2003
CY10.11.2003
LU10.11.2003
MC30.11.2003
Former [2004/39]AT12.03.2003
BE12.03.2003
CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
DK12.06.2003
SE12.06.2003
PT16.06.2003
CY10.11.2003
LU10.11.2003
Former [2004/36]AT12.03.2003
BE12.03.2003
CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
DK12.06.2003
SE12.06.2003
PT16.06.2003
CY10.11.2003
Former [2004/23]AT12.03.2003
BE12.03.2003
CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
DK12.06.2003
SE12.06.2003
PT16.06.2003
Former [2004/10]AT12.03.2003
BE12.03.2003
CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
SE12.06.2003
PT16.06.2003
Former [2003/50]AT12.03.2003
CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
SE12.06.2003
PT16.06.2003
Former [2003/47]AT12.03.2003
CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
PT16.06.2003
Former [2003/46]CH12.03.2003
FI12.03.2003
GR12.03.2003
LI12.03.2003
NL12.03.2003
PT16.06.2003
Former [2003/43]CH12.03.2003
FI12.03.2003
LI12.03.2003
NL12.03.2003
PT16.06.2003
Former [2003/41]CH12.03.2003
FI12.03.2003
LI12.03.2003
NL12.03.2003
Former [2003/40]CH12.03.2003
LI12.03.2003
Cited inInternational search[Y]WO9735584  (LILLY CO ELI [US]) [Y] 1-22 * claims 1,2 *;
 [A]WO9846601  (LILLY CO ELI [US], et al) [A] 1-22 * claims 14,26 *;
 [A]WO9846227  (LILLY CO ELI [US], et al) [A] 1-22 * claims 14,26 *;
 [PX]EP0908186  (LILLY CO ELI [US]) [PX] 1-22 * claims 7-9,17 *;
 [Y]  - MILLAN M. J. ET AL, "WAY 100635 enhances both the antidepressant actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex", EUROPEAN JOURNAL OF PHARMACOLOGY, (19980112), vol. 341, no. 2/3, pages 165 - 167, XP000904847 [Y] 1-22 * abstract * * see discussion *

DOI:   http://dx.doi.org/10.1016/S0014-2999(97)01445-3
 [T]  - PHARMACEUTICAL INFORMATION NETWORK, "Celecoxib linked to GI deaths in five patients", PNN PHARMACOTHERAPY LINE, (19990420), page 1, URL: http://pharminfo.com/pubs/pnn/pnn38_4.html, (20000419), XP002136045 [T] 1-22 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.